← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Hesperos, Llc
Orlando, FL
$26,643,407
Total funding
11
Grants
Funding over time
peak $5.4M · FY2016–25$10M$7.5M$5M$2.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,643,407 · 11
By mechanism
R44$23,524,204 · 7
U44$2,000,000 · 1
R43$1,119,203 · 3
Investigators at Hesperos, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Functional integrated human-on-a-chip systems for Alzheimer's research$1,507,755
R44 · FY2019 · AG
Functional integrated human-on-a-chip systems for Alzheimer's research$1,507,753
R44 · FY2020 · AG
Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia$1,500,000
R44 · FY2025 · AG
Human on a chip systems to investigate disease comorbidities common in the aged population$1,483,966
R44 · FY2020 · AG
Human on a chip systems to investigate disease comorbidities common in the aged population$1,483,966
R44 · FY2022 · AG
Human on a chip systems to investigate disease comorbidities common in the aged population$1,483,966
R44 · FY2021 · AG
Automation and validation of human on a chip systems for drug discovery$1,412,888
R44 · FY2019 · TR
Automation and validation of human on a chip systems for drug discovery$1,404,459
R44 · FY2020 · TR
Automation and validation of human on a chip systems for drug discovery$1,363,424
R44 · FY2018 · TR
Advanced Human on a Chip Systems for Drug Discovery$1,241,321
R44 · FY2016 · TR
Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency$1,000,000
U44 · FY2024 · TR
Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency$1,000,000
U44 · FY2025 · TR
Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia$902,320
R44 · FY2021 · AG
Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia$902,299
R44 · FY2022 · AG
HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform$854,765
R44 · FY2022 · HL
HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform$854,765
R44 · FY2023 · HL
Biodistribution and PK modeling of rat vs. human systems$789,413
R44 · FY2022 · ES
Biodistribution and PK modeling of rat vs. human systems$754,240
R44 · FY2021 · ES
Development of an integrated 4-organ animal model$744,745
R44 · FY2020 · ES
Development of an integrated 4-organ animal model$744,745
R44 · FY2019 · ES